NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 541.36M
Enterprise Value 322.6M
Trailing P/E N/A
Forward P/E 1-3.20
PEG Ratio (5 yr expected) 10.05
Price/Sales (ttm)N/A
Price/Book (mrq)1.92
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.98

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.62%
Return on Equity (ttm)-49.28%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.39M
Net Income Avi to Common (ttm)-11.07M
Diluted EPS (ttm)-1.41
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.19M
Total Cash Per Share (mrq)2.04
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.52
Book Value Per Share (mrq)2.29

Cash Flow Statement

Operating Cash Flow (ttm)-11.63M
Levered Free Cash Flow (ttm)-7.47M

Trading Information

Stock Price History

Beta (3Y Monthly) -0.47
52-Week Change 32.74%
S&P500 52-Week Change 37.48%
52 Week High 38.61
52 Week Low 33.12
50-Day Moving Average 34.66
200-Day Moving Average 35.60

Share Statistics

Avg Vol (3 month) 3123.08k
Avg Vol (10 day) 344.05k
Shares Outstanding 59.42M
Float 4.7M
% Held by Insiders 122.80%
% Held by Institutions 152.76%
Shares Short (Sep 28, 2018) 4248.52k
Short Ratio (Sep 28, 2018) 40.82
Short % of Float (Sep 28, 2018) 44.47%
Short % of Shares Outstanding (Sep 28, 2018) 42.64%
Shares Short (prior month Aug 31, 2018) 479.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/9
Last Split Date 3May 11, 2017